Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma Group (MREO) Exchange Rate Effect: 2023-2025

Historic Exchange Rate Effect for Mereo BioPharma Group (MREO) over the last 3 years, with Sep 2025 value amounting to -$418,000.

  • Mereo BioPharma Group's Exchange Rate Effect fell 134.72% to -$418,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $657,000, marking a year-over-year decrease of 75.75%. This contributed to the annual value of -$233,000 for FY2024, which is 108.27% down from last year.
  • Latest data reveals that Mereo BioPharma Group reported Exchange Rate Effect of -$418,000 as of Q3 2025, which was down 129.29% from $1.4 million recorded in Q2 2025.
  • Mereo BioPharma Group's Exchange Rate Effect's 5-year high stood at $1.7 million during Q4 2023, with a 5-year trough of -$1.3 million in Q4 2024.
  • Over the past 3 years, Mereo BioPharma Group's median Exchange Rate Effect value was $846,000 (recorded in 2023), while the average stood at $409,273.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first plummeted by 174.91% in 2024, then soared by 1,433.64% in 2025.
  • Over the past 3 years, Mereo BioPharma Group's Exchange Rate Effect (Quarterly) stood at $1.7 million in 2023, then crashed by 174.91% to -$1.3 million in 2024, then slumped by 134.72% to -$418,000 in 2025.
  • Its last three reported values are -$418,000 in Q3 2025, $1.4 million for Q2 2025, and $908,000 during Q1 2025.